We rely on our tumor research platform, professional technical team, and independently developed immunodeficient animal models to have accumulated a series of project experiences in syngeneic tumor transplantation, xenograft tumor transplantation, and establishment of tumor immune dual-humanization over more than twenty years. Weitongda can undertake various tumor efficacy evaluation services, including treatment methods such as cell therapy, gene therapy, and various small and large molecule drugs.